These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 196405)

  • 1. [Nature of the proteinase activated by the contact factor in human blood plasma].
    Veremeenko KN; Kizim AI; Lositskaia VM
    Vopr Med Khim; 1977; (3):391-6. PubMed ID: 196405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of TAMe (p-tosyl-L-arginine methyl ester) esterase activity of bovine plasma.
    Claxton J; Black WD; Gentry PA
    Am J Vet Res; 1978 Jul; 39(7):1235-8. PubMed ID: 677544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact activation of human plasma prorenin in vitro.
    Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP
    J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chromatographic separation of activated proteases from human plasma].
    Lehmann B; Taucher M; Kühne H; Scheuch DW
    Biomed Biochim Acta; 1988; 47(4-5):363-71. PubMed ID: 2467663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions.
    Baumgarten CR; Nichols RC; Naclerio RM; Lichtenstein LM; Norman PS; Proud D
    J Immunol; 1986 Aug; 137(3):977-82. PubMed ID: 3522740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma arginine esterase in cystic fibrosis: kinetics of activation, identification as plasma kallikrein, reaction with alpha 2-macroglobulin and comparison with levels in normal plasma.
    Bury AF; Barrett AJ
    Pediatr Res; 1982 Aug; 16(8):613-20. PubMed ID: 6180371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of aprotinin and gabexate mesilate on human plasma kallikrein.
    Nakahara M
    Arzneimittelforschung; 1983; 33(7):969-71. PubMed ID: 6194800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.
    Colman RW; Mattler L; Sherry S
    J Clin Invest; 1969 Jan; 48(1):23-32. PubMed ID: 4237065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose dependence of endotoxin-induced activation of the plasma contact system: an in vitro study.
    Roeise O; Bouma BN; Stadaas JO; Aasen AO
    Circ Shock; 1988 Dec; 26(4):419-30. PubMed ID: 2463883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of precipitating antibodies to pancreatic kallikrein on arginine esterase contact activation in human and rabbit blood].
    Karpitskiĭ VV; Guz SIa
    Vopr Med Khim; 1979; 25(3):242-5. PubMed ID: 452486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Method of simultaneous determination of kallikrein, plasmin and thrombin precursors and inhibitors in human blood plasma].
    Gomazkov OA; Komissarova NV
    Biull Eksp Biol Med; 1976 May; 81(5):632-4. PubMed ID: 132976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of proteolysis inhibitors on serum proteinase activity and its antitryptic activity in postischemic toxemia].
    Protsenko VA; Kharchenko VZ; Veselov VF; Spitsyn IF; Bogadel'nikov IV
    Farmakol Toksikol; 1978; 41(6):693-6. PubMed ID: 720581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials.
    van der Kamp KW; van Oeveren W
    J Biomed Mater Res; 1994 Mar; 28(3):349-52. PubMed ID: 7521336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact-activated fibrinolysis: role of surface concentration and high-molecular-weight kininogen.
    Goldsmith GH
    J Lab Clin Med; 1980 Aug; 96(2):222-31. PubMed ID: 7400661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
    Seligsohn U; Osterud B; Brown SF; Griffin JH; Rapaport SI
    J Clin Invest; 1979 Oct; 64(4):1056-65. PubMed ID: 479368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of contact activation of rabbit blood (kallikrein and plasmin systems].
    Komissarova NV; Gomazkov OA
    Biull Eksp Biol Med; 1976; 81(4):390-2. PubMed ID: 132208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of plasma kallikrein selective inhibitors.
    Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
    Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.